College of Contemporary Health

College of Contemporary Health Making Health Care Professionals world leaders in Obesity Care and Digital Health We concentrate on evidence-based learning.

At the College of Contemporary Health (CCH), we are passionate about developing and delivering accessible online healthcare programmes, focused on obesity care and weight management, digital health, and behaviour change. Science, and a problem-centred learning approach, are the key components of all of our courses. This allows our learners to develop practical skills that can be applied in real-world scenarios. The curriculum for our courses is overseen by our outstanding Academic Advisory Board, comprised of the most influential voices in their respective fields; all of whom are at the cutting edge of both research and clinical practice and this knowledge is reflected in CCH courses. In 2016, CCH's postgraduate qualifications were validated; this reflects the academic rigour and robust nature of all of our courses.

The worldwide prevalence of has more than doubled over the past three decades, accompanied by sharp rises in weight-re...
13/01/2026

The worldwide prevalence of has more than doubled over the past three decades, accompanied by sharp rises in weight-related conditions such as type 2 , cardiovascular disease, and several cancers.

This escalating challenge places increasing strain on systems and national economies across the globe.

Against this backdrop, a new international study suggests that glucagon-like peptide-1 receptor agonists, commonly referred to as medications, could play a substantial role in addressing obesity and its related complications at scale.

The analysis was co-led by investigators from Mass General Brigham and aimed to estimate how many adults worldwide might benefit from these medicines.

A global analysis of data from 99 countries suggests over 27 percent of adults worldwide may be eligible for GLP-1 weight-loss medicines, raising urgent questions around access, equity, and obesity care.

A large longitudinal study conducted in South Korea has found that , particularly abdominal obesity, is associated with...
12/01/2026

A large longitudinal study conducted in South Korea has found that , particularly abdominal obesity, is associated with a higher risk of developing in young adulthood.

The research suggests that fat distribution around the abdomen is a more important predictor of migraine onset than overall body weight as measured by body mass index.

The findings were published in the medical journal Neurology (American Academy of Neurology (AAN)).

A large South Korean cohort study of over six million young adults finds that abdominal obesity is a stronger predictor of migraine risk than body mass index, highlighting the role of fat distribution and inflammation.

Severe asthma attacks among adolescents with excess weight may be significantly reduced with the use of newer weight-los...
07/01/2026

Severe asthma attacks among adolescents with excess weight may be significantly reduced with the use of newer weight-loss medications such as and , according to a new observational study.

The research found that emergency room visits for were cut by more than half among teenagers who were prescribed a glucagon-like peptide-1 ( ) receptor agonist.

The findings were reported on 29 December in JAMA Network Open.

“Our findings suggest a potential dual benefit for this population, where a single class of medication could address both and lower risk for asthma exacerbation, thereby potentially reducing the burden of two common and interconnected ,” the researchers concluded.

New research suggests GLP-1 weight-loss medications may significantly reduce asthma-related emergency visits and medication use among adolescents with excess weight.

The oral form of launched on Monday, with the starting dose now available in pharmacies across the country. Higher dos...
06/01/2026

The oral form of launched on Monday, with the starting dose now available in pharmacies across the country.

Higher doses are expected to arrive by the end of the week, according to reports accompanying the launch.

The pill was approved by the U.S. Food and Drug Administration on 22 December for the treatment of .

It is also approved to reduce the risk of and in people who are living with obesity or who are overweight.

The launch of the pill follows the blockbuster success of Novo Nordisk’s injectable Wegovy, which has been available since 2021.

Demand for the injection was so high that it remained in short supply until February 2025.

Novo Nordisk has positioned the oral formulation as an alternative for people who prefer not to use injections, while maintaining similar clinical effectiveness.

The oral version of Wegovy is now available in pharmacies following FDA approval. Clinical trial data show weight loss comparable to injections, with pricing, dosing and insurance details explained.

Parents and carers are being urged to avoid using bottles to help toddlers fall asleep, after new research found clear l...
06/01/2026

Parents and carers are being urged to avoid using bottles to help toddlers fall asleep, after new research found clear links between the practice, early childhood , and excess .

The study, published in the Australian and New Zealand Journal of Public Health, was led by researchers at the University of Sydney and drew on data from more than 700 toddlers participating in Western Sydney University’s Healthy Smiles Healthy Kids (HSHK) cohort study.

The long running study follows children from birth to examine factors influencing oral health and broader outcomes.

Bottle feeding toddlers to sleep is linked to higher risks of dental decay and excess weight, according to new research from Australia following children from birth.

Almost 30 per cent of general practitioners in the UK are now using tools in consultations with patients, according to...
05/01/2026

Almost 30 per cent of general practitioners in the UK are now using tools in consultations with patients, according to new research, despite concerns that such use could lead to clinical errors and legal action.

The findings highlight how rapidly has moved into everyday general practice, largely as a response to intense workload pressures.

Tools such as are being used to support tasks including appointment summaries, elements of clinical reasoning and routine administrative work.

However, this expansion is taking place in what researchers describe as a largely unregulated environment, leaving many clinicians uncertain about which tools are safe, appropriate and compliant with NHS England standards.

Nearly 30 per cent of UK GPs are now using AI tools in patient consultations. New research highlights rapid adoption, regulatory gaps, and concerns over safety, liability and data security.

As the year comes to a close, we wanted to pause and say thank you.This year at CCH was shaped by healthcare professiona...
19/12/2025

As the year comes to a close, we wanted to pause and say thank you.

This year at CCH was shaped by healthcare professionals choosing to keep learning – often alongside busy, demanding roles.

A few highlights from 2025:

📄 1 research paper published
🎓 3 new CPD-accredited short courses released
👥 77 new CCH learners welcomed
💯 100% commitment to evidence-based, practice-focused education

Every number represents real professionals investing in their knowledge and confidence, and we’re grateful to be part of that journey.

Thank you for learning with us this year.

We’re looking forward to what’s ahead.

In 2025, healthcare professionals invested over 24,000 hours in learning with CCH. Here is a snapshot of what we achieved together this year.

A comprehensive systematic review published online on 8 December in Annals of Internal Medicine suggests that glucagon-l...
18/12/2025

A comprehensive systematic review published online on 8 December in Annals of Internal Medicine suggests that glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 RAs, have little or no effect on the risk of developing cancers associated with .

The review was led by Eric Ko, MD, PhD, of the Harvard T.H. Chan School of Public Health in Boston, and examined data from randomised, placebo-controlled trials involving people treated with RAs for type 2 or overweight and obesity.

While these medications have transformed in recent years, concerns have persisted about their long-term safety, including potential risk.

A major systematic review finds little or no evidence that GLP-1 receptor agonists meaningfully affect obesity-related cancer risk, highlighting the need for longer-term data.

A large retrospective, claims-based cohort study has found that metabolic delivers greater long-term benefits and lo...
17/12/2025

A large retrospective, claims-based cohort study has found that metabolic delivers greater long-term benefits and lower overall health care costs over two years compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in adults living with severe .

The analysis suggests that, in real-world clinical practice, surgical approaches may offer more durable outcomes than alone for this population.



A large retrospective study suggests metabolic bariatric surgery delivers greater and more durable two-year weight loss, with lower overall costs, compared with GLP-1 receptor agonists in people living with severe obesity.

Babies born to mothers with may begin life with a markedly different gut microbiome, a factor that could influence the...
16/12/2025

Babies born to mothers with may begin life with a markedly different gut microbiome, a factor that could influence their metabolism and long-term health, according to new research from Nazarbayev University (NU).

The study, led by researchers Almagul Kushugulova and Samat Kozhakhmetov, explored how maternal obesity may shape the early development of the gut in infants.

The research team followed 24 mothers and their babies from birth to six months of age, analysing stool samples using advanced DNA sequencing techniques.

By comparing infants born to mothers with obesity with those born to mothers without obesity, the researchers identified clear differences in the composition and diversity of during early life.

A new study from Nazarbayev University finds that infants born to mothers with obesity show early differences in gut microbiome composition, with potential implications for metabolism and long-term health.

A new study has highlighted the profound emotional and psychological toll experienced by people living with who are pr...
15/12/2025

A new study has highlighted the profound emotional and psychological toll experienced by people living with who are preparing for metabolic and .

The research found that internalised is widespread among individuals seeking specialist care, with many reporting depressive symptoms, reduced self-esteem, and deep feelings of self-criticism linked to their weight.

The pilot study, titled 𝘛𝘩𝘦 𝘉𝘶𝘳𝘥𝘦𝘯 𝘧𝘳𝘰𝘮 𝘞𝘪𝘵𝘩𝘪𝘯—𝘈𝘯 𝘐𝘯𝘥𝘪𝘢𝘯 𝘗𝘪𝘭𝘰𝘵 𝘚𝘵𝘶𝘥𝘺 𝘰𝘯 𝘞𝘦𝘪𝘨𝘩𝘵 𝘉𝘪𝘢𝘴 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘭𝘪𝘴𝘢𝘵𝘪𝘰𝘯, was published in Obesity Surgery Journal, the international journal of the International Federation for the Surgery and other therapies for Obesity (IFSO).

A new Indian study highlights the high levels of internalised weight bias among people preparing for metabolic and bariatric surgery. More than 71 percent of participants reported self-directed stigma, with many experiencing shame, reduced self-worth, and depressive symptoms. Clinicians emphasise th...

A five-year clinical study has begun in Greater to examine the real-world effectiveness of the anti-obesity medication...
15/12/2025

A five-year clinical study has begun in Greater to examine the real-world effectiveness of the anti-obesity medication , marketed in the United Kingdom as Mounjaro.

The trial aims to understand how the treatment affects long-term outcomes when delivered through .

The first participants have now been enrolled after visiting their GP, marking the formal start of the project.

Greater Manchester has launched a five-year real-world trial of the anti-obesity medication tirzepatide, known as Mounjaro, involving up to 3,000 participants. The study will assess long-term effects on health, employment, sick leave, and quality of life through GP-led primary care.

Address

90 London Road
London
SE16LN

Telephone

+442037734895

Website

Alerts

Be the first to know and let us send you an email when College of Contemporary Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to College of Contemporary Health:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Mission

At the College of Contemporary Health (CCH), we are passionate about developing and delivering accessible online healthcare programmes, focused on weight management and obesity care. We concentrate on evidence-based learning. Science, and a problem-centred learning approach, are the key components of all of our courses. This allows our learners to develop practical skills that can be applied in real-world scenarios. The curriculum for our courses is overseen by our outstanding Academic Advisory Board, comprised of the most influential voices in the obesity care and weight management field; all of whom are at the cutting edge of both research and clinical practice and this knowledge is reflected in all CCH courses. http://www.contemporaryhealth.co.uk/